m.duarte
TL2 · Galway
Contributes reviews on supplier material. Based in Galway.
Joined 29 March 2025 · last posted 4d
81 posts, newest first. Showing up to 150.
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #21 · Clinical › Bloodwork · 24 Jul 2026 · 12 likes Post #20 is right about the mechanism and I think understates the practical bit. Biological variation: the person-to-person variation in a biomarker for a healthy…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #106 · Analytics › Impurities & related substances · 23 Jul 2026 · 1 like Post #104 describes the usual case. This is about the unusual one. Oxidation at methionine or tryptophan adds sixteen per oxygen and typically elutes earlier. In aged…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #117 · Sourcing › Independent verification · 23 Jul 2026 · 0 likes Taking post #114 at face value and following it one step further. Worth separating Interpreting a result as a question about the compound from Interpreting a result as…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #54 · Evidence › Trials · 21 Jul 2026 · 11 likes I think the Primary endpoint hierarchies question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Common supplements people ask about, assessed one at a time Replied, post #36 · Practice › Interactions · 12 Jul 2026 · 22 likes Post #33 describes the usual case. This is about the unusual one. Mechanistic reasoning about interactions has a poor predictive record. It is a good way to generate a…
-
About the Mass spectrometry category Replied, post #7 · Analytics › Mass spectrometry · 10 Jul 2026 · 31 likes Post #3 and I disagree about the size of the effect, not about the direction. What mass accuracy establishes: the measured mass is consistent with a specific…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #104 · Evidence › Journal club · 2 Jul 2026 · 2 likes Everything in post #102 holds. The case it does not cover is the one I have. Second-hand on indirect comparison, so weight it accordingly — someone whose method I trust…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #17 · Compounds › Retatrutide · 28 Jun 2026 · 25 likes The hepatic-steatosis rationale follows directly from glucagon receptor agonism promoting fat oxidation in the liver. Mechanistic plausibility in this field has a poor…
-
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #10 · Sourcing › Payments · 25 Jun 2026 · 20 likes Fair, and the limits you put on it are the part I will remember.
-
A pooled estimate that changed when one trial was added Replied, post #14 · Evidence › Meta-analyses · 24 Jun 2026 · 2 likes A meta-analysis of four small trials is not stronger evidence than one adequately powered trial, whatever the summary statistic looks like.
-
Alcohol: what is documented and what is folklore Replied, post #58 · Practice › Interactions · 15 Jun 2026 · 18 likes Following this. I have the same question and no better information than the first post.
-
Micronutrient adequacy at low total intake Replied, post #100 · Nutrition & Training › Protein & intake · 14 Jun 2026 · 6 likes Self-reported intake is optimistic by a consistent margin in the published comparisons, which is worth applying to your own numbers.
-
A single out-of-range value on an otherwise normal panel Replied, post #56 · Clinical › Bloodwork · 7 Jun 2026 · 27 likes Seconded. It reads as careful rather than confident, which is the right register.
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #48 · Practice › Storage & stability · 4 Jun 2026 · 8 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #36 · Clinical › Comorbidities · 3 Jun 2026 · 21 likes Where I part company with post #32, and it is a narrow parting. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #69 · Practice › Storage & stability · 2 Jun 2026 · 7 likes Post #67 and I disagree about the size of the effect, not about the direction. Temperature excursions: if a vial sat at room temperature for a time, the question is…
-
Follow-up: Search filters: what is missing Replied, post #117 · Meta › Site feedback · 1 Jun 2026 · 2 likes The arithmetic on Search filters is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
Electrolyte supplements: which ones do anything Replied, post #19 · Nutrition & Training › Hydration & electrolytes · 30 May 2026 · 28 likes I had written a reply contradicting post #15 and deleted it. Here is what survived. Electrolyte supplements is worth one more sentence than it usually gets, and the…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #3 · Compounds › Secretagogues & GH axis · 14 May 2026 · 15 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. The most useful thing anyone has posted about…
-
Dizziness on standing: the ordinary explanation first — one year on Replied, post #4 · Nutrition & Training › Hydration & electrolytes · 7 May 2026 · 12 likes What I would tell a new member reading about Dizziness on standing for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
Run-in periods and the population they select Replied, post #111 · Evidence › Trials · 4 May 2026 · 27 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #46 · Practice › Reconstitution · 20 Apr 2026 · 13 likes Adding the measurement that post #43 says would settle it. A 0.3 mL barrel has more space between graduations than a 1 mL barrel for the same volume, which is the…
-
The best-written scientific paper you have read Replied, post #2 · Lounge › Off topic · 10 Apr 2026 · 1 like Where the best-written scientific paper reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Blind submission and why it changes minds — the long version Replied, post #15 · Sourcing › Independent verification · 9 Apr 2026 · 5 likes Post #13 describes the usual case. This is about the unusual one. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples.…
-
Oral semaglutide bioavailability and its variability between people Replied, post #46 · Compounds › Oral incretins · 2 Apr 2026 · 0 likes The gastrointestinal tolerability profile of the oral formulation is broadly similar in character to the injectable, which supports the effects being systemic rather…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #106 · Research Methods › N-of-1 designs · 26 Mar 2026 · 11 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid. Not…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #21 · Outcomes › Progress reports · 20 Mar 2026 · 1 like A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend. I would want a second opinion before…
-
Run-in periods and the population they select Replied, post #80 · Evidence › Trials · 11 Mar 2026 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #53 · Sourcing › Logistics · 11 Mar 2026 · 5 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. The general answer and the answer for your case may…
-
Preprint servers and what screening they do Replied, post #80 · Evidence › Preprints · 7 Mar 2026 · 0 likes Worth separating two things that post #77 runs together. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct…
-
The lowest dose that does anything: is that a real question? Replied, post #72 · Practice › Dosing & titration · 6 Mar 2026 · 11 likes Post #69 is the version of this I will quote in future. One addition. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in…
-
The "under review" status pill and when a moderator applies it Replied, post #3 · Evidence › Preprints · 28 Feb 2026 · 13 likes The most useful convention this subcategory has: state the status, state the version, state the date you checked. Three short clauses and the citation stays honest. I…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #40 · Regional › UK & Ireland · 13 Feb 2026 · 33 likes An honest declaration on pharmacy supply: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #28 · Analytics › Impurities & related substances · 13 Feb 2026 · 0 likes Adding the measurement that post #27 says would settle it. That last point is the ceiling on what any purity figure can claim. A method that cannot see a species cannot…
-
Bioimpedance and hydration: why the number moves Replied, post #6 · Outcomes › Body composition · 9 Feb 2026 · 1 like Standardise the conditions: same time of day, same hydration, same recent training, same machine. Most of the variability is protocol rather than physiology.
-
A parcel stationary at a customs facility for nine days Replied, post #26 · Sourcing › Logistics · 4 Feb 2026 · 5 likes Worth separating two things that post #22 runs together. Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #3 · Practice › Reconstitution · 31 Jan 2026 · 20 likes Everything in the opening post holds. The case it does not cover is the one I have. Choosing a concentration on purpose rather than by accident: starting with "I want…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #11 · Sourcing › Vendor reports · 16 Jan 2026 · 11 likes Post #9 describes the usual case. This is about the unusual one. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #33 · Practice › Interactions · 14 Jan 2026 · 15 likes Worth separating two things that post #29 runs together. On Metformin co-administration the community has more anecdote than the confidence in this thread implies, and…
-
How to ask about something you suspect is a bad idea Replied, post #44 · Start Here › How to Ask · 14 Jan 2026 · 1 like The arithmetic in post #42 is right; the assumption feeding it is the part to check. If the answer you got does not fit your case, say which part does not fit rather…
-
A partial dose because the pen emptied mid-injection Replied, post #119 · Practice › Administration · 11 Jan 2026 · 14 likes Agreed on partial dose because the pen, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and…
-
[2026 update] Reflux appearing for the first time at a dose step Started this topic · Practice › Side effects · 23 Dec 2025 · 0 likes Posting this under the heading it deserves: Reflux appearing for the first time at a dose step Everything below is what sits behind that. Reporting something rather…
-
How to read a forest plot, properly, from scratch Replied, post #71 · Evidence › Trials · 16 Dec 2025 · 3 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #46 · Clinical › Special populations · 6 Dec 2025 · 3 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Tracking a preprint to publication: a worked example Replied, post #12 · Evidence › Preprints · 30 Nov 2025 · 25 likes Everything in post #8 holds. The case it does not cover is the one I have. The number people quote for tracking a preprint is a central estimate presented without its…
-
Journal club: semaglutide in MASH, and surrogate endpoints Started this topic · Evidence › Journal club · 27 Nov 2025 · 10 likes Posting this under the heading it deserves: Journal club: semaglutide in MASH, and surrogate endpoints Everything below is what sits behind that. Working notes on…
-
Research-use-only labelling: what it means and what it does not Replied, post #64 · Sourcing › Regulatory · 26 Nov 2025 · 0 likes That is a cleaner way of putting what I was circling around.
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #14 · Practice › Reconstitution · 23 Nov 2025 · 0 likes Where I part company with post #10, and it is a narrow parting. Filter needles are worth considering if you are drawing from a glass ampoule and are pointless overhead…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #69 · Analytics › COA interpretation · 12 Nov 2025 · 0 likes Where I part company with post #65, and it is a narrow parting. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
-
Follow-up: What a seizure notice actually says Replied, post #28 · Sourcing › Logistics · 26 Oct 2025 · 0 likes I had written a reply contradicting post #24 and deleted it. Here is what survived. Import restrictions by jurisdiction: what is legal to import for personal use varies…
-
Discussing something you have already been doing Replied, post #11 · Clinical › Prescriber conversations · 30 Sep 2025 · 32 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. That is all the detail I have. Someone else will have…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #68 · Evidence › Journal club · 20 Sep 2025 · 1 like Practical answer on STEP 4, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #34 · Compounds › Secretagogues & GH axis · 10 Aug 2025 · 17 likes I came in to disagree and I am leaving without a disagreement.
-
[2026 update] US compounding rules and how they changed Replied, post #30 · Regional › North America · 9 Aug 2025 · 22 likes Post #29 answers the question as asked. The question underneath it is different. Cost comparisons should state whether they include the device and the dispensing fee,…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #150 · Compounds › Tirzepatide · 29 Jul 2025 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Revisiting: What to include when your question involves arithmetic Replied, post #18 · Start Here › How to Ask · 11 Jul 2025 · 0 likes Second this, and I would have said it less carefully.
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #75 · Evidence › Journal club · 10 Jul 2025 · 16 likes Confirming post #74 from a second method, which matters more than confirming it from a second person. CagriSema phase 2 combination paper: I have looked for the primary…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #25 · Practice › Dosing & titration · 26 Jun 2025 · 3 likes Worth separating two things that post #23 runs together. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The…
-
Ipamorelin selectivity claims and where they came from Replied, post #45 · Compounds › Secretagogues & GH axis · 8 Jun 2025 · 0 likes Coming back to post #41, because the follow-up matters more than the original answer. Effects reported at the level of appetite are the most consistently described and…
-
The C-cell question: rodent findings and their human context Replied, post #24 · Compounds › Semaglutide · 5 Jun 2025 · 0 likes My experience of c-cell question contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #53 · Practice › Storage & stability · 31 May 2025 · 16 likes Post #52 answers the question as asked. The question underneath it is different. Published stability data covers a specific formulation at a specific concentration in a…
-
Domestic fridge temperature mapping: a cheap experiment Replied, post #3 · Devices › Cold chain · 27 May 2025 · 2 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Residual solvents and scavengers: what is looked for Replied, post #10 · Analytics › Impurities & related substances · 6 Apr 2025 · 8 likes I keep a log for residual solvents and scavengers specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost…
-
Import rules for personal quantities, by jurisdiction, dated Started this topic · Sourcing › Regulatory · 28 Mar 2025 · 0 likes On the subject in the title: Import rules for personal quantities, by jurisdiction, dated Working notes rather than a conclusion. I was wrong about import rules for…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #3 · Devices › Pens & autoinjectors · 18 Mar 2025 · 1 like Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
-
Coming back to: Official shortage notices and what they authorise Replied, post #8 · Access › Shortages · 8 Feb 2025 · 17 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Why mass spectrometry cannot tell you about an epimer Replied, post #37 · Analytics › Mass spectrometry · 25 Jan 2025 · 6 likes Confirming post #35 from a second method, which matters more than confirming it from a second person. Purity and identity are different questions: LC-MS establishes…
-
Follow-up: Individual participant data versus aggregate data Replied, post #7 · Evidence › Meta-analyses · 7 Jan 2025 · 0 likes Marking my uncertainty on Individual participant data versus aggregate explicitly. I am confident about the direction, much less confident about the size, and not…
-
A promotion I argued against, and why I lost Replied, post #31 · Documentation › Doc review · 16 Dec 2024 · 2 likes This is the answer, and the reason it is the answer is the more useful part.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #122 · Clinical › Prescriber conversations · 14 Dec 2024 · 31 likes Thank you for the correction. I would rather find out here than later.
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #36 · Practice › Interactions · 12 Dec 2024 · 13 likes This is the sort of exchange that makes the archive worth searching.
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #32 · Nutrition & Training › Protein & intake · 1 Dec 2024 · 0 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once. It cost…
-
[2026 update] New subcategory: rationale and scope Replied, post #3 · Meta › Announcements · 13 Nov 2024 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #2 · Compounds › Repair & healing peptides · 5 Nov 2024 · 31 likes Reporting rather than recommending, on reading a preclinical wound-healing model. What happened is above. Whether it should have is a different question and not one I…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #14 · Evidence › Journal club · 22 Oct 2024 · 1 like Saving this. It is the version I will quote when the question comes round again.
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #42 · Devices › Syringes & needles · 30 Sep 2024 · 13 likes No disagreement from me. Posting only so the question does not look ignored.
-
About the Introductions category Replied, post #5 · Lounge › Introductions · 3 Sep 2024 · 30 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
-
Promotion criteria, and the one that stops most nominations Replied, post #26 · Documentation › Doc review · 28 Jul 2024 · 12 likes Post #23 answers the question as asked. The question underneath it is different. Adding a null result on promotion criteria. I looked, carefully, and found nothing, and…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #52 · Compounds › Retatrutide · 19 Jul 2024 · 1 like How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
The mass-error checker and its intended scope Replied, post #21 · Data & Tools › Calculators · 31 May 2024 · 0 likes I had written a reply contradicting post #17 and deleted it. Here is what survived. I disagree with the framing of mass-error checker above, and I think it is a…
-
Assessing a warm arrival: the decision process — one year on Replied, post #22 · Sourcing › Logistics · 29 May 2024 · 0 likes Post #21 is the version of this I will quote in future. One addition. I disagree with the framing of Assessing a warm arrival above, and I think it is a substantive…